79.29
price up icon1.50%   1.17
after-market Handel nachbörslich: 79.40 0.11 +0.14%
loading

Merck Co Inc Aktie (MRK) Neueste Nachrichten

pulisher
Aug 01, 2025

Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer - Insider Monkey

Aug 01, 2025
pulisher
Aug 01, 2025

Ascentage Pharma to Participate in Evercore China Biotech Summit - GlobeNewswire Inc.

Aug 01, 2025
pulisher
Jul 31, 2025

N.J.-based Merck announces $3B in cost cutting measures including layoffs - NJ.com

Jul 31, 2025
pulisher
Jul 31, 2025

Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM - Insider Monkey

Jul 31, 2025
pulisher
Jul 30, 2025

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns - Benzinga

Jul 30, 2025
pulisher
Jul 30, 2025

Merck & Co., Inc. (NYSE:MRK) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 30, 2025
pulisher
Jul 30, 2025

Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Jul 30, 2025
pulisher
Jul 29, 2025

Merck & Co.’s Winrevair Growing Into The Revenue Driver Needed Post-Keytruda LOE - insights.citeline.com

Jul 29, 2025
pulisher
Jul 29, 2025

Merck Stock Is Almost A Classical Benjamin Graham Investment - Seeking Alpha

Jul 29, 2025
pulisher
Jul 29, 2025

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Merck will lay off employees and shed some real estate to cut $3 billion in costs - MSN

Jul 29, 2025
pulisher
Jul 29, 2025

Earnings call transcript: Merck Q2 2025 beats EPS, stock dips on revenue miss - Investing.com

Jul 29, 2025
pulisher
Jul 29, 2025

Why Is Merck Stock Falling On Tuesday?Merck & Co (NYSE:MRK) - Benzinga

Jul 29, 2025
pulisher
Jul 29, 2025

MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales - AlphaStreet

Jul 29, 2025
pulisher
Jul 29, 2025

Merck Cuts $3 Billion in Costs as Keytruda Reign Nears End - MSN

Jul 29, 2025
pulisher
Jul 29, 2025

Merck posts Q2 earnings miss, unveils cost-cutting initiative - Proactive financial news

Jul 29, 2025
pulisher
Jul 29, 2025

Merck Mounts $3 Billion Revamp as Keytruda Price Pressure Looms - Bloomberg

Jul 29, 2025
pulisher
Jul 29, 2025

Merck & Co., Inc. Reports Mixed Second-Quarter 2025 Results - Tokenist

Jul 29, 2025
pulisher
Jul 29, 2025

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results - BioSpace

Jul 29, 2025
pulisher
Jul 29, 2025

Merck & Co. Announces New Restructuring Program - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

Merck in Charts: KEYTRUDA sales surge 9% Y/Y, GARDASIL dips 54% in Q2 (NYSE:MRK) - Seeking Alpha

Jul 29, 2025
pulisher
Jul 29, 2025

Merck plans $3B annual cost cuts as Keytruda faces patent cliff (MRK:NYSE) - Seeking Alpha

Jul 29, 2025
pulisher
Jul 29, 2025

Merck & Co Inc. Q2 Profit Decreases, But Beats Estimates - Nasdaq

Jul 29, 2025
pulisher
Jul 28, 2025

Migraine Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored | GlaxoSmithKline, Merck & Co., Inc., Pfizer, Bausch Health, Amgen, Abbvie Inc., AstraZeneca, Eli Lilly and Co - Barchart.com

Jul 28, 2025
pulisher
Jul 28, 2025

Merck Q2 Earnings Preview: What to expect? - Seeking Alpha

Jul 28, 2025
pulisher
Jul 28, 2025

How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

Merck & Co., Inc. Earnings Preview: Insights and ExpectationsNews and Statistics - IndexBox

Jul 28, 2025
pulisher
Jul 28, 2025

Leerink Partners Slashes PT on Merck & Co. (MRK) to $92 From $115 - Insider Monkey

Jul 28, 2025
pulisher
Jul 27, 2025

Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup - Insider Monkey

Jul 27, 2025
pulisher
Jul 25, 2025

UBS Bullish on Merck (MRK) Following Verona Pharma Purchase - MSN

Jul 25, 2025
pulisher
Jul 24, 2025

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Companion Animal Medicine Market Key Players AnalysisMerck & - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

Merck Announces Fourth-Quarter 2025 Dividend - BioSpace

Jul 23, 2025
pulisher
Jul 22, 2025

Merck Declares $0.81 Per Share Q4 Dividend: Key Dates and Payment Details Revealed - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

Lobbying Update: $4,980,000 of MERCK & CO INC lobbying was just disclosed - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Is Weakness In Merck & Co., Inc. (NYSE:MRK) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects? - 富途牛牛

Jul 21, 2025
pulisher
Jul 21, 2025

Merck Commits to Veeva Vault CRM – Company Announcement - Financial Times

Jul 21, 2025
pulisher
Jul 20, 2025

Morgan Stanley Lowered the Firm’s PT on Merck & Co (MRK), Kept a Hold Rating - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jul 19, 2025
pulisher
Jul 18, 2025

Peter Lynch's Investment Strategy: A Detailed Analysis of MERCK & CO INC (MRK) - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Merck’s (MRK) Dividend History: A Track Record of Consistency - Insider Monkey

Jul 18, 2025
pulisher
Jul 18, 2025

Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating - Insider Monkey

Jul 18, 2025
drug_manufacturers_general NVO
$48.19
price up icon 2.38%
$296.88
price up icon 0.60%
drug_manufacturers_general NVS
$115.30
price up icon 1.37%
$113.18
price up icon 0.79%
drug_manufacturers_general PFE
$23.49
price up icon 0.86%
Kapitalisierung:     |  Volumen (24h):